How Effective Are New Drugs in Stroke Prevention?

For decades, warfarin was the only oral blood thinner available to reduce the risk of stroke for patients with atrial fibrillation.

Warfarin use requires ongoing blood tests to monitor its effect and has numerous drug and food interactions. Now a number of non-vitamin K antagonist oral anticoagulant (NOAC) drugs are available for patients with atrial fibrillation. Continue reading “How Effective Are New Drugs in Stroke Prevention”